Your browser doesn't support javascript.
loading
Future directions in esophageal cancer therapy.
Wald, Ori; Smaglo, Brandon; Mok, Henry; Groth, Shawn S.
Afiliação
  • Wald O; Division of General Thoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
  • Smaglo B; Division of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Mok H; Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA.
  • Groth SS; Division of General Thoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Ann Cardiothorac Surg ; 6(2): 159-166, 2017 Mar.
Article em En | MEDLINE | ID: mdl-28447005
ABSTRACT
Resection techniques for esophageal carcinoma continue to evolve, from endoscopic mucosal resection or endoscopic submucosal dissection for early stage disease to standard and robot-assisted minimally invasive esophagectomy as part of multimodal therapy for locally advanced disease. Though currently limited to assessing conduit perfusion and sentinel lymph nodes, embedded technology in the robotic surgical platform will likely play an expanded role during esophagectomy in the future. The use of targeted therapies, checkpoint inhibitors, engineered immune cell therapy, and cancer vaccines show promise in the treatment of systemic disease. Radiation therapy techniques are becoming increasingly sophisticated and they may play a more active role in stage IV disease in the future.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article